Concepedia
Statistics
Publications
52
Citations
3.8K
H-Index
33
Active since
1995
Affiliations
University of Wales(Current)
Cardiff University
Tenovus Cancer Care
Velindre Cancer Centre
AstraZeneca (United Kingdom)
Stephen Hiscox is an author at University of Wales specializing in oncology, molecular oncology, and cancer cell signaling.
Publications per year
1995–2020
Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells
Helen E. Jones, Lindy Goddard, Julia M.W. Gee et al. · Endocrine Related Cancer · 2004 · 298 citations · Full text
Medicine, Oncology, Pharmacology +17
Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells
Stephen Hiscox, L. Morgan, Tim P. Green et al. · Breast Cancer Research and Treatment · 2005 · 273 citations
Medicine, Cell Biology, Oncology +16
Protein Kinase CK2 Triggers Cytosolic Zinc Signaling Pathways by Phosphorylation of Zinc Channel ZIP7
Stephen Hiscox, Robert I. Nicholson, Christer Högstrand et al. · Science Signaling · 2012 · 268 citations
Life Sciences, Biochemistry, Molecular Biology +8
Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of β-catenin phosphorylation
Stephen Hiscox, Wen G. Jiang, Kathrin Obermeier et al. · International Journal of Cancer · 2005 · 264 citations
Life Sciences, Cell Biology, Oncology +17
ZIP7-Mediated Intracellular Zinc Transport Contributes to Aberrant Growth Factor Signaling in Antihormone-Resistant Breast Cancer Cells
Petra Vichova, Nicola Jordan, Stephen Hiscox et al. · Endocrinology · 2008 · 237 citations · Full text
Medicine, Molecular Biology, Oncology +17
1–5 of 52